TrialAllergy2018
Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma.
T B Casale et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
54 papers cite it
this paperpooled ittrialcites it
TrialAllergy2018
T B Casale et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.